Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review

M Jensterle, M Rizzo, M Haluzík, A Janež - Advances in therapy, 2022 - Springer
The approval of once daily liraglutide, 3.0 mg, and once weekly semaglutide, 2.4 mg, for
chronic weight management provides a novel effective strategy against obesity. The reliable …

The stomach in health and disease

RH Hunt, M Camilleri, SE Crowe, EM El-Omar, JG Fox… - Gut, 2015 - gut.bmj.com
The stomach is traditionally regarded as a hollow muscular sac that initiates the second
phase of digestion. Yet this simple view ignores the fact that it is the most sophisticated …

Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5

RF Kushner, S Calanna, M Davies, D Dicker… - …, 2020 - Wiley Online Library
Objective The obesity epidemic is a public health concern, warranting further research into
pharmacological treatments for weight management (WM) as an adjunct to lifestyle …

Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals

BKA Dayyeh, A Acosta, M Camilleri, MS Mundi… - Clinical …, 2017 - Elsevier
Background & Aims Although bariatric surgery is the most effective therapy for obesity, only
a small proportion of candidates undergo this surgery. Endoscopic sleeve gastroplasty …

Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up

G Lopez-Nava, RZ Sharaiha, EJ Vargas, F Bazerbachi… - Obesity surgery, 2017 - Springer
Background Endoscopic sleeve gastroplasty (ESG) is a technique for managing mild to
moderately obese patients. We aimed to evaluate the long-term outcomes, reproducibility …

Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy

A Acosta, M Camilleri, A Shin, MI Vazquez-Roque… - Gastroenterology, 2015 - Elsevier
Background & Aims Weight loss after pharmacotherapy varies greatly. We aimed to examine
associations of quantitative gastrointestinal and psychological traits with obesity, and to …

White paper AGA: POWER—practice guide on obesity and weight management, education, and resources

A Acosta, S Streett, MD Kroh, LJ Cheskin… - Clinical …, 2017 - Elsevier
The epidemic of obesity continues at alarming rates, with a high burden to our economy and
society. The American Gastroenterological Association understands the importance of …

Current paradigms in the etiology of obesity

HC Kadouh, A Acosta - Techniques in Gastrointestinal Endoscopy, 2017 - Elsevier
The global prevalence of obesity continues to rise at an alarming rate and 37.7% of US
adults are obese. Understanding the causes of excessive weight gain is extremely …

Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up

C Ricci, M Gaeta, E Rausa, E Asti, F Bandera… - Obesity surgery, 2015 - Springer
Background The first aim of the study was to estimate weight loss and major modifiable risk
factors after bariatric surgery. The second aim was to investigate the relationship between …

Homeostatic regulation of food intake

L Cifuentes, A Acosta - Clinics and research in hepatology and …, 2022 - Elsevier
Food intake and energy expenditure are key regulators of body weight. To regulate food
intake, the brain must integrate physiological signals and hedonic cues. The brain plays an …